JP4840858B2 - 癌ワクチン - Google Patents

癌ワクチン Download PDF

Info

Publication number
JP4840858B2
JP4840858B2 JP2006073159A JP2006073159A JP4840858B2 JP 4840858 B2 JP4840858 B2 JP 4840858B2 JP 2006073159 A JP2006073159 A JP 2006073159A JP 2006073159 A JP2006073159 A JP 2006073159A JP 4840858 B2 JP4840858 B2 JP 4840858B2
Authority
JP
Japan
Prior art keywords
cells
sox6
peptide
cancer
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006073159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007246451A (ja
JP2007246451A5 (enExample
Inventor
正博 戸田
良 植田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keio University
Original Assignee
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keio University filed Critical Keio University
Priority to JP2006073159A priority Critical patent/JP4840858B2/ja
Publication of JP2007246451A publication Critical patent/JP2007246451A/ja
Publication of JP2007246451A5 publication Critical patent/JP2007246451A5/ja
Application granted granted Critical
Publication of JP4840858B2 publication Critical patent/JP4840858B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2006073159A 2006-03-16 2006-03-16 癌ワクチン Expired - Fee Related JP4840858B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006073159A JP4840858B2 (ja) 2006-03-16 2006-03-16 癌ワクチン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006073159A JP4840858B2 (ja) 2006-03-16 2006-03-16 癌ワクチン

Publications (3)

Publication Number Publication Date
JP2007246451A JP2007246451A (ja) 2007-09-27
JP2007246451A5 JP2007246451A5 (enExample) 2009-04-30
JP4840858B2 true JP4840858B2 (ja) 2011-12-21

Family

ID=38591117

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006073159A Expired - Fee Related JP4840858B2 (ja) 2006-03-16 2006-03-16 癌ワクチン

Country Status (1)

Country Link
JP (1) JP4840858B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5267969B2 (ja) * 2007-12-04 2013-08-21 学校法人慶應義塾 癌ワクチン
TWI543767B (zh) * 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
WO2010032696A1 (ja) * 2008-09-18 2010-03-25 学校法人慶應義塾 がんの診断方法と治療方法
JP5984113B2 (ja) * 2012-06-11 2016-09-06 学校法人慶應義塾 がん免疫療法
WO2016129335A1 (ja) * 2015-02-09 2016-08-18 株式会社ライフアートビレッジ 免疫細胞療法のためのペプチドスクリーニング方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002355054A1 (en) * 2001-11-30 2003-06-10 Keio University Human glioma antigen originating in testis

Also Published As

Publication number Publication date
JP2007246451A (ja) 2007-09-27

Similar Documents

Publication Publication Date Title
JP4764874B2 (ja) Ｍｈｃ分子を結合する腫瘍関連ペプチド
KR20210156320A (ko) 개인맞춤화 신생물 백신을 위한 조성물 및 방법
JP2013241417A (ja) 癌ワクチン組成物
EP3199627B1 (en) Tumor antigen peptides
JP5114403B2 (ja) Ｈｌａ−ａ３スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なｓａｒｔ３由来ペプチド
CN106243213B (zh) 一种肿瘤相关抗原XAGE-1b短肽及应用
CN102481333B (zh) 免疫诱导剂
JP5065273B2 (ja) Ｈｌａ−ａ２４分子結合性ｋｉｆ由来ペプチド
CN106279392B (zh) 肿瘤相关抗原XAGE-1b短肽及其应用
Schmitz et al. Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
WO2012144726A2 (ko) 폴로-유사 키나아제 1의 종양항원 단백질 또는 유전자
JP5267969B2 (ja) 癌ワクチン
JP4840858B2 (ja) 癌ワクチン
WO2016093243A1 (ja) 腫瘍抗原ペプチド
JP4840866B2 (ja) 癌ワクチン
CN105163754A (zh) 前列腺特异性肿瘤抗原及其用途
Shichijo et al. ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients
Akiyama et al. Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail
Li et al. Identification of a new HLA-A* 0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587
Tiriveedhi et al. Identification of HLA-A24-restricted CD8+ cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer–associated antigen
WO2017086354A1 (ja) Ｈｌａ－ａ１１拘束性細胞傷害性ｔ細胞エピトープペプチド
JP5709396B2 (ja) がんワクチン
Palermo et al. Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
JP5984113B2 (ja) がん免疫療法
Izgi et al. Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090316

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090330

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090330

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090707

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110906

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110929

R150 Certificate of patent or registration of utility model

Ref document number: 4840858

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141014

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees